加载中
NASDAQHealthcareMedical - Specialties
最新数据
US$127.51
+US$1.45 · +1.15%
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
前收盘价
US$127.51
+US$1.45 · +1.15%
盘前
US$126.45
−US$1.06 · -0.83%
10月12日 5:47 ET
盘中时间采用ET。市场数据可能有所延迟。
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
日内区间
当前US$127.51
52周区间
当前US$127.51
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
持有
估值
58
合理估值
情绪
58
多空交织
风险
48
风险偏高
动量
48
中性
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
日内区间
当前US$127.51
52周区间
当前US$127.51
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2026财年 | 2025财年 | 2024财年 | 2023财年 | 2022财年 |
|---|---|---|---|---|---|
| 营收 | 2.49亿 USD | 2.41亿 USD | 2.16亿 USD | 2.19亿 USD | 1.84亿 USD |
| 销货成本 | 9086万 USD | 9010.8万 USD | 8293.7万 USD | 8538.7万 USD | 7524.5万 USD |
| 毛利 | 1.58亿 USD | 1.51亿 USD | 1.33亿 USD | 1.34亿 USD | 1.09亿 USD |
| 研究与开发 | 2030.8万 USD | 1951.8万 USD | 1930万 USD | 2049万 USD | 1576.7万 USD |
| 销售、一般及管理费用 | 1.19亿 USD | 1.15亿 USD | 1.11亿 USD | 1.1亿 USD | 8862.1万 USD |
| 营业费用 | 1.4亿 USD | 1.35亿 USD | 4.05亿 USD | 1.3亿 USD | 1.04亿 USD |
| 利息支出 | 1069.2万 USD | 1185.9万 USD | 569.7万 USD | 477万 USD | 388.5万 USD |
| 折旧和摊销 | 2327.1万 USD | 2452.7万 USD | 3157.4万 USD | 3313.4万 USD | 2506.8万 USD |
| 营业利润 | 1851.1万 USD | 1633.6万 USD | −2.72亿 USD | 332万 USD | 470.2万 USD |
| 净利润 | 671.2万 USD | −197.4万 USD | −2.54亿 USD | 93万 USD | 187.1万 USD |
公司数据更新于 2026年10月12日。
第三方分析师预期可能变化，并非 GoAI 建议。
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI2154.75万0.00%2.3万亿 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM1817.18万0.02%787.4亿 USD0.19%US$278.94+0.49%
Keeley Dividend ETFKDVD1777.76万2.22%800万 USD0.90%US$27.7170.00%
Vanguard Extended Market ETFVXF819.8万0.01%954亿 USD0.05%US$235+0.80%
Fidelity Enhanced Small Cap ETFFESM683.03万0.10%64.1亿 USD0.28%US$45.46+0.46%
iShares Russell 2000 Growth ETFIWO630.96万0.05%139.17亿 USD0.24%US$356.78+0.94%
Dimensional - US Targeted Value ETFDFAT535.89万0.02%301.22亿 USD0.33%US$67.27-0.43%
Dimensional - US Small Cap ETFDFAS462.1万0.01%338.69亿 USD0.31%US$78.35+0.32%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMKeeley Dividend ETFKDVDVanguard Extended Market ETFVXFFidelity Enhanced Small Cap ETFFESMiShares Russell 2000 Growth ETFIWODimensional - US Targeted Value ETFDFATDimensional - US Small Cap ETFDFASAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
